Genetic Test Evaluation

understanding how genetic tests impact patient management

Genetic Testing for Individuals Clinically Diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia

December 11, 2018

This report evaluates the clinical utility of genetic testing for catecholaminergic polymorphic ventricular tachycardia (CPVT) in individuals clinically diagnosed (defined as eliciting atrial arrhythmias and bidirectional or polymorphic ventricular tachycardia by stress test) with CPVT for management of the disorder leading to improved health outcomes.